
Objectives Even though nurses assume a frontline role in antimicrobial stewardship (AMS) programs, their integration remains suboptimal. This study evaluated nurses' knowledge, practices, and interprofessional collaboration regarding antibiotic therapy in a Moroccan university hospital, and suggested strategies potentially leading to more rational deployment.
Background Data on dalbavancin use in vascular graft infections (VGI) are lacking. We aimed to report our experience of its efficacy and safety. Methods This retrospective monocentric study included patients with VGI, according to MAGIC criteria, who received at least one dalbavancin dose between 01/2021 and 11/2024, followed for at least one year. One-year relapse-free survival and safety were assessed. Results Seven patients with a median Charlson's score of 2 (IQR (Bouza et al., 2018; Seltzer et al., 2003; Frazier et al., 2023 [2], [3], [4])), median age of 62 years (IQR [61–73]), received a median of two (IQR (Molina et al., 2022; Bouza et al., 2018 [1], [2])) dalbavancin injections. Before dalbavancin initiation, patients had received a median of four antibiotic regimens (IQR (Seltzer et al., 2003; Frazier et al., 2023; Turner et al., 2022; Hidalgo-Tenorio et al., 2023 [3], [4], [5], [6])) and undergone one surgical procedure (IQR (Molina et al., 2022; Bouza et al., 2018 [1], [2])). Partial graft replacement was performed in three patients (42.9%). At one year follow-up, all patients were alive, actively followed, without relapse or adverse event. Conclusion Dalbavancin showed promising outcomes in a limited subset of Gram-positive pathogen VGI patients.
Objective To investigate a possible association among adults aged 50–84 years between acute pyelonephritis (APN) as compared to lower urinary tract infection (LUTI) and subsequent herpes zoster (HZ). Methods We conducted a retrospective cohort study using the TriNetX network. Participants aged 50–84 years with APN were compared with those with LUTI. Propensity score matching was performed using baseline characteristics. After a 1-month lag period, the primary outcome was a new diagnosis of herpes zoster during 6 months of follow-up. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Age-stratified analyses and sensitivity analyses using 3-month and 9-month follow-up periods were performed. Results After 1:1 propensity score matching, each cohort initially comprised 102,084 participants. Following application of the 1-month lag period, the primary outcome analysis included 101,949 participants with APN and 102,040 participants with LUTI. During the 6-month follow-up, herpes zoster occurred in 299 participants with APN and 141 with LUTI, corresponding to crude event proportions of 0.29% and 0.14%, respectively. Compared with LUTI, APN was associated with an increased risk of herpes zoster (HR, 2.13; 95% CI, 1.75–2.61). This association was observed among participants aged 50–64 years (HR, 1.74; 95% CI, 1.32–2.29) and 65–84 years (HR, 2.40; 95% CI, 1.81–3.18). Sensitivity analyses using 3-month and 9-month follow-up periods yielded consistent findings. Conclusion Among adults aged 50–84 years during a 6-month follow-up period, APN was associated with a higher short-term risk of subsequent herpes zoster than LUTI.
Objectives To assess whether higher circulating cell-free mitochondrial deoxyribonucleic acid concentrations within the first 24 h are associated with higher all-cause mortality at 28–30 days in adults with sepsis. Methods PubMed, Scopus, and Web of Science Core Collection were searched on October 17, 2026. Eligible observational studies will assess early circulating concentrations and prognosis. At least two reviewers will independently select studies, extract data, and assess risk of bias using Quality In Prognosis Studies or the Joanna Briggs Institute analytical cross-sectional tool. Certainty will be assessed using Grading of Recommendations Assessment, Development and Evaluation. Meta-analysis will require at least three independent studies with compatible estimates for the same outcome. Inverse-variance random-effects models will use restricted maximum likelihood and modified Hartung–Knapp intervals. Association measures, discrimination, and concentration differences will be synthesized separately. When a cohort reports both mortality horizons, 28-day estimates will be preferred; 30-day-only estimates will remain eligible. Expected results The review will characterize associations with mortality and organ dysfunction, discrimination, and additional prognostic information, accounting for baseline severity, clinical setting, and measurement conditions. Conclusions The synthesis will inform further evaluation of this biomarker for risk assessment in sepsis.